High value chemicals for pharmaceuticals could be made cheaper and greener by new catalysts

Making high-value chemicals requires many years and large financial investment

3 Oct 2019
Laura Sisman
Administrator / Office Personnel

Product news

The catalysts made by researchers at the University of Warwick and GoldenKeys High-Tech Materials Co., Ltd. in China can tailor make chemicals. The ability to selectively make the chemicals means they can potentially be made quicker, cheaper and higher purity.

The process of making high-value chemicals for uses such as the pharmaceutical or electronics chemical industry requires many years of work and a very high financial investment, with a large amount of side products going to waste.

However, in research published in the ACS journal Organic Letters, the paper: ‘Probing the Effects of Heterocyclic Functionality in [(Benzene) Ru (TsDPENR)CI] Catalysts for Asymmetric Transfer Hydrogenation’, shows how scientists are able to tailor conditions in the catalyst to make the molecule required.

The research project between the University of Warwick and the GoldenKeys High-Tech Materials Co., Ltd., a Speciality Material Company led by Dr. Yingjian Xu FRSC in China, has resulted in the development of a series of new catalysts for the asymmetric synthesis of alcohols which could be used for high value chemicals such as pharmaceuticals and electronics chemicals, potentially making it faster, cheaper and more environmentally sustainable as less chemicals are required under the catalytic conditions.

Researchers were able to make the catalyst by making the molecules’ ligands - which act as building blocks, bind to the metal ruthenium.
This means that scientists can pick and choose which molecules to bind together to make a catalyst and in turn make the chemical required in a much faster and more sustainable way.

In some cases the ligands are ‘bidentate’ - meaning they form two bonds to the metal, and in other cases they are ‘tridentate’ - forming three bonds to the metal. Knowing how each ligand will bind also helps the identification of the optimal active form and the conditions required for the target application.

Professor Martin Wills from the Department of Chemistry at the University of Warwick comments “The ability to make high-value chemicals through our new series of catalysts using ruthenium metal means that they can be made much more sustainably.”

“If this method is used in the pharmaceutical and electronics chemical industries for example then products and intermediates can potentially be made more cheaply and quickly with higher purity for consumers and reduce waste as less material is needed to make the catalyst, unlike traditional stoichiometric methods.” Dr. Yingjian Xu of GoldenKeys High-Tech Materials Co., Ltd. Added.

Want more of the latest science news straight to your inbox? Become a SelectScience member for free today>>

Links

Tags

Sample PreparationSample preparation can improve the quality and speed of separation techniques. Products to assist sample preparation include filtration equipment, evaporators, membranes and sieves.Compound LibrariesCompound libraries, or chemical libraries, are used in drug discovery for the identification of potential therapeutics compounds. Used in conjunction with high-throughput screening, the libraries of stored compounds are often generated for specific purposes as a drug target or disease model. Cheminformatics are commonly used when designing a compound library and software can be used to analyze the screening process.  Discovery SoftwareComputational techniques used in both the chemistry and biology aspects of drug discovery, for data acquisition, processing and storage. Software is used for analysis of pathways, target identification, genomics, proteomics, modelling, lead identification, compound analysis and drug modelling among many others. Compound AnalysisCompound analysis is used to discover specific compounds that could be promising candidates for pharmaceutical use. This potential is identified when compounds have the desired effect, such as interaction with a target protein, during high throughput screening.Active PharmaceuticalsThe Active Pharmaceutical Ingredient (API) of a drug is the component that causes the direct effect of the product. The remaining inactive components are known as excipients.CatalystPharmaceuticalsPharmaceuticals are medicinal drugs used in healthcare to diagnose, prevent, cure and treat illnesses. Pharmaceuticals that are excreted after use appear in wastewater and can have detrimental effects on the environment.